₹33.3*
MRP ₹37
10% off
₹31.45*
MRP ₹37
15% CB
₹5.55 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Prescription drugWhats That
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
Also Explore
உற்பத்தியாளர்/சந்தைப்படுத்துபவர் :
மனோ ஃபார்மா
உட்கொள்ளும் வகை :
வாய்வழி
திரும்பப் பெறும் கொள்கை :
திரும்பப் பெற முடியாது
இந்த மருந்துக்கு காலாவதியாகும் தேதி அல்லது அதற்குப் பிறகு :
Jan-27
Drug-Drug Interactions
ChlordiazepoxideSodium oxybate
Critical
Critical
Drug-Drug Interactions
Login/Sign Up
ChlordiazepoxideSodium oxybate
Critical
How does the drug interact with Vibatryp-H Tablet:
Taking Vibatryp-H Tablet with Sodium oxybate increases the risk of breathing difficulty or low blood pressure.
How to manage the interaction:
Taking Vibatryp-H Tablet with Sodium oxybate is generally avoided as it can lead to an interaction, it can be taken if prescribed by a doctor. However, if you experience dizziness, shortness of breath, excessive sweating, or blurred vision, contact your doctor. Do not discontinue any medications without consulting a doctor.
Taking Vibatryp-H Tablet with Sodium oxybate increases the risk of breathing difficulty or low blood pressure.
How to manage the interaction:
Taking Vibatryp-H Tablet with Sodium oxybate is generally avoided as it can lead to an interaction, it can be taken if prescribed by a doctor. However, if you experience dizziness, shortness of breath, excessive sweating, or blurred vision, contact your doctor. Do not discontinue any medications without consulting a doctor.
Critical
How does the drug interact with Vibatryp-H Tablet:
Combining Vibatryp-H Tablet and Dronedarone may increase the risk of irregular heartbeat.
How to manage the interaction:
Although combining Vibatryp-H Tablet with Dronedarone may result in an interaction, it can be used if a doctor recommends it. If you have any heart problems or electrolyte imbalances, you may be susceptible. If you have sudden dizziness, lightheadedness, fainting, or fast or rapid heartbeats during therapy, get emergency medical help. Do not discontinue any medication without consulting a doctor.
Combining Vibatryp-H Tablet and Dronedarone may increase the risk of irregular heartbeat.
How to manage the interaction:
Although combining Vibatryp-H Tablet with Dronedarone may result in an interaction, it can be used if a doctor recommends it. If you have any heart problems or electrolyte imbalances, you may be susceptible. If you have sudden dizziness, lightheadedness, fainting, or fast or rapid heartbeats during therapy, get emergency medical help. Do not discontinue any medication without consulting a doctor.
Critical
How does the drug interact with Vibatryp-H Tablet:
Using Vibatryp-H Tablet together with Procarbazine can increase the risk of serotonin syndrome (A condition resulting from the accumulation of high levels of serotonin in the body. Serotonin is especially a mood stabilizer).
How to manage the interaction:
Although using Procarbazine and Vibatryp-H Tablet together may cause an interaction, they can be taken if prescribed by a doctor. Consult a doctor if you have symptoms such as confusion, hallucination, fits, blood pressure alteration, increased heart rate, fever, excessive sweating, shivering or shaking, blurred vision, pain in the muscles or stiffness, incoordination, stomach cramps, nausea, vomiting, and diarrhea. Inform a doctor if you have recently taken Vibatryp-H Tablet. Do not discontinue any medications without consulting a doctor.
Using Vibatryp-H Tablet together with Procarbazine can increase the risk of serotonin syndrome (A condition resulting from the accumulation of high levels of serotonin in the body. Serotonin is especially a mood stabilizer).
How to manage the interaction:
Although using Procarbazine and Vibatryp-H Tablet together may cause an interaction, they can be taken if prescribed by a doctor. Consult a doctor if you have symptoms such as confusion, hallucination, fits, blood pressure alteration, increased heart rate, fever, excessive sweating, shivering or shaking, blurred vision, pain in the muscles or stiffness, incoordination, stomach cramps, nausea, vomiting, and diarrhea. Inform a doctor if you have recently taken Vibatryp-H Tablet. Do not discontinue any medications without consulting a doctor.
Critical
How does the drug interact with Vibatryp-H Tablet:
Taking Vibatryp-H Tablet and Ziprasidone may increase the risk of irregular heartbeat.
How to manage the interaction:
Although there is a interaction between Vibatryp-H Tablet with Ziprasidone, but it can be taken together if prescribed by your doctor. However, consult your doctor immediately if you experience sudden dizziness, lightheadedness, fainting, or fast or rapid heartbeats . Do not discontinue any medication without consulting a doctor.
Taking Vibatryp-H Tablet and Ziprasidone may increase the risk of irregular heartbeat.
How to manage the interaction:
Although there is a interaction between Vibatryp-H Tablet with Ziprasidone, but it can be taken together if prescribed by your doctor. However, consult your doctor immediately if you experience sudden dizziness, lightheadedness, fainting, or fast or rapid heartbeats . Do not discontinue any medication without consulting a doctor.
AmitriptylineSaquinavir
Critical
How does the drug interact with Vibatryp-H Tablet:
Combining Vibatryp-H Tablet and Saquinavir may increase the risk of irregular heartbeat.
How to manage the interaction:
Although combining Vibatryp-H Tablet with Saquinavir may result in an interaction, it can be used if a doctor recommends it. If you have any heart problems or electrolyte imbalances, you may be susceptible. If you have sudden dizziness, lightheadedness, fainting, or fast or rapid heartbeats during therapy, get emergency medical help. Do not discontinue any medication without consulting a doctor.
Combining Vibatryp-H Tablet and Saquinavir may increase the risk of irregular heartbeat.
How to manage the interaction:
Although combining Vibatryp-H Tablet with Saquinavir may result in an interaction, it can be used if a doctor recommends it. If you have any heart problems or electrolyte imbalances, you may be susceptible. If you have sudden dizziness, lightheadedness, fainting, or fast or rapid heartbeats during therapy, get emergency medical help. Do not discontinue any medication without consulting a doctor.
AmitriptylineHalofantrine
Critical
How does the drug interact with Vibatryp-H Tablet:
Combining Vibatryp-H Tablet and Halofantrine may increase the risk of irregular heartbeat.
How to manage the interaction:
Although combining Vibatryp-H Tablet with Halofantrine may result in an interaction, it can be used if a doctor recommends it. If you have any heart problems or electrolyte imbalances, you may be susceptible. If you have sudden dizziness, lightheadedness, fainting, or fast or rapid heartbeats during therapy, get emergency medical help. Do not discontinue any medication without consulting a doctor.
Combining Vibatryp-H Tablet and Halofantrine may increase the risk of irregular heartbeat.
How to manage the interaction:
Although combining Vibatryp-H Tablet with Halofantrine may result in an interaction, it can be used if a doctor recommends it. If you have any heart problems or electrolyte imbalances, you may be susceptible. If you have sudden dizziness, lightheadedness, fainting, or fast or rapid heartbeats during therapy, get emergency medical help. Do not discontinue any medication without consulting a doctor.
AmitriptylineIsocarboxazid
Critical
How does the drug interact with Vibatryp-H Tablet:
Combining Isocarboxazid with Vibatryp-H Tablet can increase the risk of serotonin syndrome (increase serotonin hormone).
How to manage the interaction:
Although using Isocarboxazid and Vibatryp-H Tablet together may cause an interaction, they can be taken if prescribed by a doctor. Consult a doctor if you have symptoms such as confusion, hallucination, fits, blood pressure alteration, increased heart rate, fever, excessive sweating, shivering or shaking, blurred vision, pain in the muscles or stiffness, incoordination, stomach cramps, nausea, vomiting, and diarrhea. Inform a doctor if you have recently taken Vibatryp-H Tablet. Do not discontinue any medications without consulting a doctor.
Combining Isocarboxazid with Vibatryp-H Tablet can increase the risk of serotonin syndrome (increase serotonin hormone).
How to manage the interaction:
Although using Isocarboxazid and Vibatryp-H Tablet together may cause an interaction, they can be taken if prescribed by a doctor. Consult a doctor if you have symptoms such as confusion, hallucination, fits, blood pressure alteration, increased heart rate, fever, excessive sweating, shivering or shaking, blurred vision, pain in the muscles or stiffness, incoordination, stomach cramps, nausea, vomiting, and diarrhea. Inform a doctor if you have recently taken Vibatryp-H Tablet. Do not discontinue any medications without consulting a doctor.
AmitriptylineGrepafloxacin
Critical
How does the drug interact with Vibatryp-H Tablet:
Combining Vibatryp-H Tablet and Grepafloxacin may increase the risk of irregular heartbeat.
How to manage the interaction:
Although combining Vibatryp-H Tablet with Grepafloxacin may result in an interaction, it can be used if a doctor recommends it. If you have sudden dizziness, lightheadedness, fainting, or fast or rapid heartbeats during therapy, get emergency medical help. Do not discontinue any medication without consulting a doctor. Note: Grepafloxacin is no longer available in the market. Grepafloxacin should not be combined with any other medications.
Combining Vibatryp-H Tablet and Grepafloxacin may increase the risk of irregular heartbeat.
How to manage the interaction:
Although combining Vibatryp-H Tablet with Grepafloxacin may result in an interaction, it can be used if a doctor recommends it. If you have sudden dizziness, lightheadedness, fainting, or fast or rapid heartbeats during therapy, get emergency medical help. Do not discontinue any medication without consulting a doctor. Note: Grepafloxacin is no longer available in the market. Grepafloxacin should not be combined with any other medications.
AmitriptylineBepridil
Critical
How does the drug interact with Vibatryp-H Tablet:
Combining Vibatryp-H Tablet and Bepridil may increase the risk of irregular heartbeat.
How to manage the interaction:
Although combining Vibatryp-H Tablet with Bepridil may result in an interaction, it can be used if a doctor recommends it. If you have sudden dizziness, lightheadedness, fainting, or fast or rapid heartbeats during therapy, get emergency medical help. Do not discontinue any medication without consulting a doctor.
Combining Vibatryp-H Tablet and Bepridil may increase the risk of irregular heartbeat.
How to manage the interaction:
Although combining Vibatryp-H Tablet with Bepridil may result in an interaction, it can be used if a doctor recommends it. If you have sudden dizziness, lightheadedness, fainting, or fast or rapid heartbeats during therapy, get emergency medical help. Do not discontinue any medication without consulting a doctor.
Critical
How does the drug interact with Vibatryp-H Tablet:
The combination of Vibatryp-H Tablet and Potassium chloride may cause stomach and upper intestinal discomfort. (Only applicable to an oral preparation)
How to manage the interaction:
Although co-administration of Vibatryp-H Tablet and Potassium chloride is not recommended as it can possibly lead to an interaction, they can be taken if prescribed by a doctor. If you experience severe stomach pain, bloating, sudden dizziness or lightheadedness, nausea, vomiting (in particular with blood), decreased hunger, and black stools while taking these medications, consult a doctor immediately. Do not discontinue any medications without talking to a doctor.
The combination of Vibatryp-H Tablet and Potassium chloride may cause stomach and upper intestinal discomfort. (Only applicable to an oral preparation)
How to manage the interaction:
Although co-administration of Vibatryp-H Tablet and Potassium chloride is not recommended as it can possibly lead to an interaction, they can be taken if prescribed by a doctor. If you experience severe stomach pain, bloating, sudden dizziness or lightheadedness, nausea, vomiting (in particular with blood), decreased hunger, and black stools while taking these medications, consult a doctor immediately. Do not discontinue any medications without talking to a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Product Substitutes
மது
பாதுகாப்பற்றது
Vibatryp-H Tablet 10's எடுத்துக்கொள்ளும்போது மது அருந்துவதைத் தவிருங்கள், ஏனெனில் இது அதிகரித்த தூக்கம் மற்றும் தலைச்சுற்றலை ஏற்படுத்தும்.
கர்ப்பம்
பாதுகாப்பற்றது
நீங்கள் கர்ப்பமாக இருந்தால் மருத்துவர் பரிந்துரைக்காத வரையில் Vibatryp-H Tablet 10's எடுத்துக்கொள்வதைத் தவிர்க்கவும், ஏனெனில் இது பிறப்பு குறைபாடுகளை ஏற்படுத்தக்கூடும்.
தாய்ப்பால் கொடுக்கும் காலம்
எச்சரிக்கை
Vibatryp-H Tablet 10's எடுத்துக்கொள்வதற்கு முன்பு உங்கள் மருத்துவரை அணுகவும்; தாய்ப்பால் கொடுக்கும் தாய்மார்கள் Vibatryp-H Tablet 10's எடுத்துக்கொள்ளலாமா வேண்டாமா என்பதை உங்கள் மருத்துவர் தீர்மானிப்பார்.
ஓட்டுநர் உரிமம்
பாதுகாப்பற்றது
Vibatryp-H Tablet 10's தூக்கம், தலைச்சுற்றுலை ஏற்படுத்தக்கூடும் மற்றும் சிந்தனை மற்றும் மோட்டார் திறன்களை பாதிக்கக்கூடும். இந்த அறிகுறிகளை நீங்கள் சந்தித்தால் வாகனம் ஓட்டவோ அல்லது இயந்திரங்களை இயக்கவோ வேண்டாம்.
கல்லீரல்
எச்சரிக்கை
கல்லீரல் பாதிப்பு உள்ள நோயாளிகளுக்கு மருந்தளவு சரிசெய்தல் தேவைப்படலாம். உங்களுக்கு கல்லீரல் பாதிப்பு அல்லது இது தொடர்பான ஏதேனும் கவலைகள் இருந்தால், தயவுசெய்து உங்கள் மருத்துவரை அணுகவும்.
சிறுநீரகம்
எச்சரிக்கை
சிறுநீரகக் கோளாறு உள்ள நோயாளிகளுக்கு மருந்தளவு சரிசெய்தல் தேவைப்படலாம். உங்களுக்கு சிறுநீரகக் கோளாறு அல்லது இது தொடர்பான ஏதேனும் கவலைகள் இருந்தால், தயவுசெய்து உங்கள் மருத்துவரை அணுகவும்.
குழந்தைகள்
பாதுகாப்பற்றது
பாதுகாப்பு மற்றும் செயல்திறன் நிறுவப்படாததால் Vibatryp-H Tablet 10's குழந்தைகளுக்கு வழங்கக்கூடாது.
Have a query?
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
